Log in

NASDAQ:GILDGilead Sciences Competitors & Alternatives

$74.92
+1.74 (+2.38 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$72.38
Now: $74.92
$74.98
50-Day Range
$72.34
MA: $77.43
$84.00
52-Week Range
$60.89
Now: $74.92
$85.97
Volume11.74 million shs
Average Volume20.20 million shs
Market Capitalization$93.98 billion
P/E Ratio19.26
Dividend Yield3.72%
Beta0.72

Competitors

Gilead Sciences (NASDAQ:GILD) Competitors and Alternatives

The following companies in the sub-industry of "biotechnology" are considered alternatives and competitors to Gilead Sciences.

Competitor NameBeat the Market RankCurrent PricePrice ChangeMarket CapRevenueP/E RatioIndicator(s)
Amgen logo
AMGN
Amgen
2.3$224.81+1.1%$130.83 billion$23.36 billion17.62Analyst Downgrade
Celgene logo
CELG
Celgene
1.7$108.24+0.0%$77.04 billion$15.28 billion14.22
Vertex Pharmaceuticals logo
VRTX
Vertex Pharmaceuticals
1.4$278.51+4.3%$68.56 billion$4.16 billion48.27
Regeneron Pharmaceuticals logo
REGN
Regeneron Pharmaceuticals
1.4$544.01+0.2%$62.70 billion$7.86 billion27.34Analyst Report
Insider Selling
High Trading Volume
Biogen logo
BIIB
Biogen
1.7$301.46+1.9%$47.94 billion$14.38 billion9.30
Seattle Genetics logo
SGEN
Seattle Genetics
1.3$152.97+0.8%$26.96 billion$916.71 million-81.37Analyst Upgrade
Alexion Pharmaceuticals logo
ALXN
Alexion Pharmaceuticals
2.9$106.14+3.1%$22.41 billion$4.99 billion9.99Analyst Report
Incyte logo
INCY
Incyte
1.4$98.22+0.5%$21.13 billion$2.16 billion-56.13Analyst Downgrade
Unusual Options Activity
BioMarin Pharmaceutical logo
BMRN
BioMarin Pharmaceutical
1.7$106.70+2.8%$18.90 billion$1.70 billion174.92Unusual Options Activity
Alnylam Pharmaceuticals logo
ALNY
Alnylam Pharmaceuticals
1.7$133.35+2.3%$16.13 billion$219.75 million-16.61
EXACT Sciences logo
EXAS
EXACT Sciences
1.8$82.11+1.6%$11.80 billion$876.29 million-105.27
Neurocrine Biosciences logo
NBIX
Neurocrine Biosciences
1.8$119.11+0.2%$11.04 billion$788.10 million64.73
Immunomedics logo
IMMU
Immunomedics
1.9$34.17+0.2%$7.61 billion$290,000.00-18.67
Ionis Pharmaceuticals logo
IONS
Ionis Pharmaceuticals
1.6$56.12+0.1%$7.58 billion$1.12 billion51.02
Exelixis logo
EXEL
Exelixis
1.8$24.40+0.3%$7.46 billion$967.78 million26.24Insider Selling
Repligen logo
RGEN
Repligen
1.2$128.07+4.1%$7.30 billion$270.24 million284.61Analyst Report
Insider Selling
United Therapeutics logo
UTHR
United Therapeutics
1.3$116.81+1.4%$5.17 billion$1.45 billion9.74
Emergent Biosolutions logo
EBS
Emergent Biosolutions
1.4$84.13+0.1%$4.43 billion$1.11 billion64.72Analyst Downgrade
Momenta Pharmaceuticals logo
MNTA
Momenta Pharmaceuticals
1.2$32.59+2.7%$3.91 billion$23.87 million-11.64Analyst Report
ChemoCentryx logo
CCXI
ChemoCentryx
1.5$63.14+6.2%$3.73 billion$36.13 million-57.93Analyst Report
Insider Selling
Amicus Therapeutics logo
FOLD
Amicus Therapeutics
1.4$12.45+2.2%$3.27 billion$182.24 million-9.58
Halozyme Therapeutics logo
HALO
Halozyme Therapeutics
2.2$23.98+1.4%$3.23 billion$195.99 million-43.60
Arena Pharmaceuticals logo
ARNA
Arena Pharmaceuticals
1.5$58.14+2.1%$2.97 billion$806.43 million-9.00Insider Selling
Novavax logo
NVAX
Novavax
1.2$45.47+5.9%$2.67 billion$18.66 million-10.98Analyst Report
Alkermes logo
ALKS
Alkermes
1.7$16.74+3.5%$2.54 billion$1.17 billion-19.02
Intercept Pharmaceuticals logo
ICPT
Intercept Pharmaceuticals
1.8$74.43+2.7%$2.52 billion$252 million-6.94
Madrigal Pharmaceuticals logo
MDGL
Madrigal Pharmaceuticals
1.6$120.00+0.4%$1.94 billionN/A-17.62
Ironwood Pharmaceuticals logo
IRWD
Ironwood Pharmaceuticals
1.4$10.65+9.9%$1.91 billion$428.41 million20.09High Trading Volume
Heavy News Reporting
Ligand Pharmaceuticals logo
LGND
Ligand Pharmaceuticals
1.4$104.77+1.0%$1.61 billion$120.28 million-30.46
Sangamo Therapeutics logo
SGMO
Sangamo Therapeutics
1.6$11.44+4.5%$1.52 billion$102.43 million-13.78
Opko Health logo
OPK
Opko Health
2.3$2.29+0.9%$1.51 billion$901.90 million-4.77Analyst Downgrade
Insider Buying
Innoviva logo
INVA
Innoviva
1.5$14.60+3.1%$1.44 billion$261.02 million8.54
Myriad Genetics logo
MYGN
Myriad Genetics
1.5$14.59+2.3%$1.06 billion$851.10 million-7.30
ImmunoGen logo
IMGN
ImmunoGen
1.4$4.86+0.2%$835.42 million$82.27 million-8.38
BioCryst Pharmaceuticals logo
BCRX
BioCryst Pharmaceuticals
1.5$5.04+3.4%$802.10 million$48.83 million-5.36
Codexis logo
CDXS
Codexis
1.5$12.30+0.4%$722.41 million$68.46 million-49.20
Molecular Templates logo
MTEM
Molecular Templates
1.6$15.89+1.6%$710.79 million$22.27 million-7.32
ZIOPHARM Oncology logo
ZIOP
ZIOPHARM Oncology
1.4$3.49+6.6%$698.59 million$150,000.00-4.99
Vanda Pharmaceuticals logo
VNDA
Vanda Pharmaceuticals
2.0$11.12+0.4%$600.05 million$227.19 million5.20Analyst Upgrade
Clovis Oncology logo
CLVS
Clovis Oncology
1.6$6.88+0.0%$529.07 million$143.01 million-0.96
NewLink Genetics logo
NLNK
NewLink Genetics
0.6N/AN/A$505.05 million$940,000.00-12.26
Dynavax Technologies logo
DVAX
Dynavax Technologies
1.5$4.94+5.5%$455.37 million$35.22 million-2.68Analyst Downgrade
Agenus logo
AGEN
Agenus
1.6$2.75+7.6%$433.51 million$150.05 million-2.22High Trading Volume
BioSpecifics Technologies logo
BSTC
BioSpecifics Technologies
1.9$61.20+2.8%$425.05 million$38.19 million18.38
PDL BioPharma logo
PDLI
PDL BioPharma
1.2$3.32+0.3%$385.77 million$54.76 million-3.53Analyst Upgrade
Spectrum Pharmaceuticals logo
SPPI
Spectrum Pharmaceuticals
1.5$3.01+0.7%$359.89 million$109.33 million-2.51Analyst Downgrade
Progenics Pharmaceuticals logo
PGNX
Progenics Pharmaceuticals
1.4$4.29+8.2%$342.92 million$34.99 million-5.57
Rigel Pharmaceuticals logo
RIGL
Rigel Pharmaceuticals
1.5$2.04+2.9%$333.77 million$59.29 million-12.75Analyst Report
Geron logo
GERN
Geron
1.4$1.64+3.0%$324.58 million$460,000.00-4.56
MannKind logo
MNKD
MannKind
1.3$1.52+2.0%$317.58 million$63.04 million-6.61
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.